Other immunodeficiency syndromes due to defects in innate immunity

Other immunodeficiency syndromes due to defects in innate immunity (Orphanet code 331193) is a grouping category that encompasses a heterogeneous collection of rare primary immunodeficiency disorders caused by defects in components of the innate immune system. The innate immune system serves as the body's first line of defense against pathogens and includes physical barriers, phagocytic cells (such as neutrophils and macrophages), natural killer (NK) cells, dendritic cells, complement proteins, and pattern recognition receptors (such as Toll-like receptors and NOD-like receptors). Defects in these pathways lead to increased susceptibility to specific groups of infections, particularly bacterial, fungal, and mycobacterial infections, depending on the precise molecular defect involved. Patients with innate immunity defects may present with recurrent, severe, or unusual infections often beginning in infancy or early childhood, though the age of onset can vary. Affected body systems primarily include the immune system, but secondary involvement of the skin, lungs, lymph nodes, bones, and gastrointestinal tract is common due to recurrent or chronic infections. Some conditions within this group include defects in Toll-like receptor signaling (e.g., IRAK-4 deficiency, MyD88 deficiency), defects in interferon pathways (e.g., STAT1 deficiency), and other signaling molecule deficiencies that impair innate immune responses. Clinical features can include invasive bacterial infections, chronic mucocutaneous candidiasis, susceptibility to mycobacterial disease, and viral infections depending on the specific pathway affected. Treatment is largely supportive and depends on the specific underlying defect. Management strategies include prophylactic antibiotics and antifungals, immunoglobulin replacement therapy in selected cases, interferon-gamma therapy for certain conditions (such as Mendelian susceptibility to mycobacterial disease), and hematopoietic stem cell transplantation in severe cases. Early diagnosis through genetic testing and immunological workup is critical for guiding appropriate management and improving outcomes.

Common questions about Other immunodeficiency syndromes due to defects in innate immunity